Adverum Biotechnologies Inc (NASDAQ:ADVM) Files An 8-K

Adverum Biotechnologies Inc (NASDAQ:ADVM) will present at the 2016 Ophthalmology Innovation Summit at the American Academy of Ophthalmology Annual Meeting. The Company’s presentation materials are furnished herewith as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference in this Item 7.01.

Story continues below

The information furnished on this Form 8-K, including Exhibit 99.1 attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any other filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

An ad to help with our costs